AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Free cash flow

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥9.12T
P/E ratio
58.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
Mar 31, 2025856,387+58.32%
Mar 31, 2024540,924-35.33%
Mar 31, 2023836,499-16.34%
Mar 31, 2022999,853+11.13%
Mar 31, 2021899,725+65.80%
Mar 31, 2020542,670+116.37%
Mar 31, 2019250,802-19.32%
Mar 31, 2018310,849

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)